Assessment of Pain Experience in Fibromyalgia
1 other identifier
observational
70
1 country
1
Brief Summary
The aim of this study is to assess pain in individuals with fibromyalgia using abstract animations and graphical body maps, and to investigate the determinants of pain quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2026
CompletedFirst Submitted
Initial submission to the registry
June 17, 2026
CompletedFirst Posted
Study publicly available on registry
June 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 24, 2027
June 23, 2026
June 1, 2026
1.2 years
June 17, 2026
June 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Painimation Mobile App
An electronic pain assessment tool designed to measure the location, nature, and intensity of pain using "pain animations and graphical images." Patients use a colorable body image to indicate the areas affected by pain. They then select from eight animations that represent their pain experiences. The size, speed, and intensity of these animations can be adjusted to accurately represent pain severity. Painimation animations are derived from the McGill Pain Questionnaire Short Form. They were developed through a human-centered design process involving patients with acute and chronic pain, clinicians, researchers, and design students. The animations correspond to the following pain qualities: "pounding," "shooting," "throbbing," "tingling," "cramping," "burning," "stabbing," and "electrifying." The area of the body affected by pain will be calculated based on the proportion of selected pixels.
At baseline (Day 1)
Secondary Outcomes (8)
PainDetect Questionnaire
At baseline (Day 1)
Central Sensitization Scale
At baseline (Day 1)
Pain Catastrophizing Scale
At baseline (Day 1)
Brief Pain Inventory
At baseline (Day 1)
Fatigue Severity Scale
At baseline (Day 1)
- +3 more secondary outcomes
Eligibility Criteria
The study will be conducted on individuals followed by the Rheumatology Department of Pamukkale University Faculty of Medicine and diagnosed with Fibromyalgia according to the 2016 ACR Fibromyalgia Syndrome diagnostic criteria.
You may qualify if:
- Being 18 years of age or older
- Being female
- Having a diagnosis of fibromyalgia syndrome according to the American Rheumatology Association Criteria
- Not receiving active physiotherapy and rehabilitation treatment
- Volunteering to participate in the study.
You may not qualify if:
- Having a serious pathology or disease that could compromise the assessment process or affect clinical decision-making (metastasis, cancer, untreated or unhealed fractures, central nervous system disease or history of diabetes, pain outside the musculoskeletal system)
- Having severe mental and psychological disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zülal TATARlead
Study Sites (1)
Pamukkale University
Denizli, Şirnak, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
June 17, 2026
First Posted
June 23, 2026
Study Start
February 3, 2026
Primary Completion (Estimated)
April 3, 2027
Study Completion (Estimated)
June 24, 2027
Last Updated
June 23, 2026
Record last verified: 2026-06